Dr Sean Patrick Abbott I, MD | |
800 N Oklahoma Ave Apt 2124, Oklahoma City, OK 73104-4420 | |
(580) 521-1994 | |
Not Available |
Full Name | Dr Sean Patrick Abbott I |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 800 N Oklahoma Ave Apt 2124, Oklahoma City, Oklahoma |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659992360 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 38157 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sean Patrick Abbott I, MD 800 Stanton L Young Blvd Ste 1400, Oklahoma City, OK 73104-5018 Ph: (405) 271-5504 | Dr Sean Patrick Abbott I, MD 800 N Oklahoma Ave Apt 2124, Oklahoma City, OK 73104-4420 Ph: (580) 521-1994 |
News Archive
Two types of guidance molecules, the attractive and the repulsive, direct the growth of nerve cells to the actual target. The designation of these molecules also describes the exclusive function that was previously attributed to them, namely to show the growing nerve fibers the way. The fundamentally new approach to the research of Prof. Dr. Schwab and his team at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) is the realization that these guidance molecules have an additional hitherto unknown role in the immune system.
Researchers from the Massachusetts General Hospital Division of Infectious Diseases are investigating the mechanism by which several important pathogenic species of bacteria deliver proteins into the cells of the organisms they are infecting.
During a meeting in Puerto Rico on Thursday to discuss recent progress towards fighting dengue, researchers voiced optimism over advances in the development of vaccines to prevent the spread of the virus, "which kills 25,000 people every year," Agence France-Presse reports. The three-day summit was hosted by the NIH, CDC and PAHO, according to the news service.
Targeted Genetics Corporation announced that its partner, Celladon Corporation, presented full data today that show the first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.
Neural stem cells have been found in epileptic brain tissue—outside the regions of the brain where they normally reside. In a group of patients who underwent surgery for epilepsy, over half had stem cells where healthy individuals do not have them, according to a study from Sahlgrenska Academy.
› Verified 7 days ago
Richard D. Kopke, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 3400 Nw 56th St, Oklahoma City, OK 73112 Phone: 405-946-5563 Fax: 405-947-6226 | |
Dr. Elena Beth Woodson, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 9900 Broadway Ext Ste 200, Oklahoma City, OK 73114 Phone: 405-608-8833 Fax: 405-608-8818 | |
Dr. John R Houck Jr., MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 921 Ne 13th Street, Department Of Surgery, Oklahoma City, OK 73104 Phone: 405-456-3409 Fax: 405-456-5952 | |
Chelsey Smith, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Wp 1290, Oklahoma City, OK 73104 Phone: 405-271-5504 | |
Jesus E Medina, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 825 Ne 10th St # 4200, Oklahoma City, OK 73104 Phone: 405-271-7559 | |
Jimmy Argo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5504 | |
Adam Johnson, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 920 Sl Young Blvd, Wp 1290, Oklahoma City, OK 73104 Phone: 405-271-5504 |